
Loading, please wait...

Loading, please wait...

Managing the mental health of patients is as crucial as antiretroviral therapy (ART) in modern clinical practice. Recent research has shed light on the correlation between HIV and depressive symptoms. A large-scale cross-sectional study conducted in Cambodia explored this relationship among 4,089 clinically stable individuals. The findings underscore a significant opportunity for intervention through improved psychosocial support systems.
The study revealed that nearly 20% of participants experienced significant depressive symptoms. Interestingly, those living in urban settings and individuals with lower education levels faced a higher risk. However, the most striking finding was the protective nature of social support. Patients who received robust emotional and practical assistance from their networks showed much better mental health outcomes. Consequently, healthcare providers must look beyond viral loads to ensure holistic patient wellbeing.
Using the Berlin Social Support Scale (BSSS), researchers quantified how assistance reduces psychological distress. Each point increase in social support was associated with a 38% reduction in the odds of depression. Furthermore, these findings align with clinical observations in India. In the Indian context, where stigma remains a significant barrier, social support acts as a primary buffer against the development of mood disorders. Therefore, integrating mental health screenings into routine ART clinic visits is essential.
Moreover, the study emphasizes that clinical stability does not equate to psychological health. Even patients with suppressed viral loads may struggle with the \"silent\" burden of depression. By fostering strong community and family support networks, clinicians can improve both treatment adherence and quality of life. In conclusion, addressing social determinants is a non-negotiable aspect of modern HIV management.
Studies indicate that approximately 19.5% to 33% of people living with HIV experience depressive symptoms. However, these rates can vary based on geographical location, level of social support, and socioeconomic factors.
Clinicians can improve support by encouraging family involvement, connecting patients with peer support groups, and reducing HIV-related stigma within the healthcare setting. Additionally, routine screening for depression helps identify those in need of early intervention.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional relationship. Always consult a qualified healthcare provider for diagnosis and treatment. Refer to the latest local and national guidelines for clinical practice.
References
1. Khan ZB et al. Social support and depressive symptoms among people living with HIV in Cambodia: a cross-sectional study. AIDS Care. 2026 Feb 18. doi: 10.1080/09540121.2026.2632324. PMID: 41705447.
2. Dhir D et al. Prevalence of depression and associated factors among HIV/AIDS patients in India: a systematic review and meta-analysis. ResearchGate. 2024.
3. Sharma A et al. Perceived social support, depression and their impact on quality of life of people living with HIV in India. ResearchGate. 2025.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A cross-sectional study shows that 19.5% of HIV patients face depressive symptoms, highlighting social support as a major protective factor in clinical care...
6 months ago

Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today